Domainex (AgeTech UK) Biomed
Drug discovery services. Domainex is Europe's fastest growing drug discovery CRO. It serves pharmaceutical, biotechnology, academic and patient foundations globally. Domainex’s drug discovery service business was established in 2001 and since that time has continued to expand to serve a wider range of international clients including UCB, FORMA Therapeutics, St George’s University, and The Institute of Cancer Research.
Funding Status:
N/A
Headquarters:
United Kingdom
Founded Date:
N/A
Employee Number:
N/A
Industry:
UK AgeTech 2020
Technology:
AgeTech Companies
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A